Condition: Endovascular Therapy · Acute Ischemic Stroke · Acute Ischemic Stroke (AIS) Related to a Distal Occlusion · Sponsor: Hyogo Medical University
RESCUE-M2O trial is a prospective, open label, blinded endpoint (PROBE), two-arm, randomized, controlled, post-market study to assess the efficacy and safety of endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.
This description comes directly from the study's public registry record.
Kazutaka Uchida, MD, PhD · 81+798-45-6458 · fu-sakakibara@hyo-med.ac.jp
Always discuss trial participation with your own doctor first.
| Hyogo Medical University | Nishinomiya, Hyōgo, Japan | Recruiting |
| Thammasat University Hospital | Khlong Luang, Changwat Pathum Thani, Thailand | Recruiting |
| S.I.S Can Tho International General Hospital | Can Tho, Can Tho City, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07347665